Previously on this blog, we have detailed a number of developments in the field of medicinal research that have involved the use of curcumin, the active ingredient in the spice turmeric. Many of these efforts have yielded positive results, showing that curcumin is helping to change the pharmaceutical landscape for the better.
A recent study published by BMC Cancer, an industry scientific journal, showed that curcumin may prove to be an effective anti-cancer agent. While other research efforts have provided similar insights, this study is unique in that it involved a form of mammary gland cancer that is common in humans.
During the research project, the investigators used a chemical process to trigger the development of tumors in mice. They then turned to a novel solution which includes curcumin to test the the effect it had on slowing or delaying tumor growth. They also utilized another test solution that did not feature curcumin in its manufacture.
The results were not definitive, but there was evidence that the curcumin-infused treatment was more effective for reducing the cancer in the mice than the one that lacked turmeric's active ingredient. More testing is needed, the researchers wrote in their abstract, but the signs are certainly encouraging.
"The data presented…demonstrate that a DHA or CCM diet alone did not reduce the incidence of tumor occurrence in mice, whereas the combined DHA diet with CCM significantly delayed tumor initiation and also significantly reduced the incidence of breast tumor in mice," the authors noted.
Learn more about this ingredient by clicking here and checking out Nutrivene Longvida Curcumin for yourself!